216 related articles for article (PubMed ID: 22901847)
1. Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist.
Hagen CP; Sørensen K; Anderson RA; Juul A
Fertil Steril; 2012 Nov; 98(5):1326-30. PubMed ID: 22901847
[TBL] [Abstract][Full Text] [Related]
2. Serum Anti-Müllerian Hormone Levels in Precocious Puberty Girls according to Stage of GnRH Agonist Treatment.
Nam HK; Kim HR; Rhie YJ; Lee KH
J Korean Med Sci; 2017 Mar; 32(3):475-479. PubMed ID: 28145651
[TBL] [Abstract][Full Text] [Related]
3. Luteinizing hormone (LH) and estradiol suppression and growth in girls with central precocious puberty: is more suppression better? Are pre-injection LH levels useful in monitoring treatment?
Kunz GJ; Sherman TI; Klein KO
J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1189-98. PubMed ID: 18183790
[TBL] [Abstract][Full Text] [Related]
4. Peripubertal changes in circulating antimüllerian hormone levels in girls.
Lashen H; Dunger DB; Ness A; Ong KK
Fertil Steril; 2013 Jun; 99(7):2071-5. PubMed ID: 23419927
[TBL] [Abstract][Full Text] [Related]
5. Two-year results of treatment with depot leuprolide acetate for central precocious puberty.
Neely EK; Hintz RL; Parker B; Bachrach LK; Cohen P; Olney R; Wilson DM
J Pediatr; 1992 Oct; 121(4):634-40. PubMed ID: 1403402
[TBL] [Abstract][Full Text] [Related]
6. Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty.
Schubert S; Hvelplund AH; Handberg A; Hagstroem S; Leunbach TL
J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):204-211. PubMed ID: 33374097
[TBL] [Abstract][Full Text] [Related]
7. Long-term GnRH-agonist treatment does not postpone central development of the GnRH pule generator in girls with idiopathic precocious puberty.
Schroor EJ; Van Weissenbruch MM; Delemarre-van de Waal HA
J Clin Endocrinol Metab; 1995 May; 80(5):1696-701. PubMed ID: 7745021
[TBL] [Abstract][Full Text] [Related]
8. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
[TBL] [Abstract][Full Text] [Related]
9. FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antimüllerian hormone in healthy girls: a longitudinal cohort study.
Hagen CP; Aksglaede L; Sørensen K; Mouritsen A; Mieritz MG; Main KM; Petersen JH; Almstrup K; Rajpert-De Meyts E; Anderson RA; Juul A
Fertil Steril; 2013 Oct; 100(4):1089-95. PubMed ID: 23850305
[TBL] [Abstract][Full Text] [Related]
10. The effect of GnRH stimulation on AMH regulation in central precocious puberty and isolated premature thelarche.
Sahin NM; Ozcan HN; Yilmaz AA; Erdeve SS; Cetinkaya S; Aycan Z
J Pediatr Endocrinol Metab; 2021 Nov; 34(11):1385-1391. PubMed ID: 34344062
[TBL] [Abstract][Full Text] [Related]
11. Inhibin B as a screening tool for early detection and treatment monitoring of central precocious puberty.
Jeong HR; Lee HJ; Shim YS; Kang MJ; Yang S; Hwang IT
Gynecol Endocrinol; 2020 Sep; 36(9):768-771. PubMed ID: 32162574
[TBL] [Abstract][Full Text] [Related]
12. GnRH agonist stimulation of the pituitary-gonadal axis in children: age and sex differences in circulating inhibin-B and activin-A.
Elsholz DD; Padmanabhan V; Rosenfield RL; Olton PR; Phillips DJ; Foster CM
Hum Reprod; 2004 Dec; 19(12):2748-58. PubMed ID: 15513981
[TBL] [Abstract][Full Text] [Related]
13. Effect of gonadotropin-releasing hormone analog on ovarian reserve in children with central precocious puberty.
Tao Y; Si C; Li H; Han J; Hou H; Yang M
Ann Palliat Med; 2020 Jan; 9(1):53-62. PubMed ID: 32005063
[TBL] [Abstract][Full Text] [Related]
14. Monitoring treatment of central precocious puberty using basal luteinizing hormone levels and practical considerations for dosing with a 3-month leuprolide acetate formulation.
Lee PA; Luce M; Bacher P
J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1249-1257. PubMed ID: 27740929
[TBL] [Abstract][Full Text] [Related]
15. Changes in body mass index during gonadotropin-releasing hormone agonist treatment for central precocious puberty and early puberty.
Lee HS; Yoon JS; Roh JK; Hwang JS
Endocrine; 2016 Nov; 54(2):497-503. PubMed ID: 27444748
[TBL] [Abstract][Full Text] [Related]
16. Serum Levels of Thyroid Stimulating Hormone and Luteinizing Hormone Are Decreased in Girls with Central Precocious Puberty after 12-Month GnRH Agonist Treatment.
Kim YJ; Chung LY; Kang E; Nam HK; Rhie YJ; Lee KH
Tohoku J Exp Med; 2020 Nov; 252(3):193-197. PubMed ID: 33087637
[TBL] [Abstract][Full Text] [Related]
17. AMH levels at central precocious puberty and premature thelarche: is it a parameter?
Sahin NM; Kinik ST; Tekindal MA; Bayraktar N
J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1351-6. PubMed ID: 26226120
[TBL] [Abstract][Full Text] [Related]
18. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
Garibaldi LR; Aceto T; Weber C; Pang S
J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
[TBL] [Abstract][Full Text] [Related]
19. Overnight luteinizing and follicle stimulating hormone profiles during GnRHa treatment in short girls born small for gestational age.
van der Kaay DC; de Jong FH; Laven JS; Hokken-Koelega AC
J Pediatr Endocrinol Metab; 2009 Feb; 22(2):161-9. PubMed ID: 19449673
[TBL] [Abstract][Full Text] [Related]
20. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
